Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Moore

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Antibiotics (Basel, Switzerland)|July 2, 2021
Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical IllnessPrakruti S Rao, Christopher C Moore, Amir A Mbonde, et al.
Critical Care Explorations|January 26, 2023
Overt and Occult Hypoxemia in Patients Hospitalized With COVID-19Shrirang M Gadrey, Piyus Mohanty, Sean P Haughey, et al.
The International Journal of Behavioral Nutrition and Physical Activity|November 30, 2023
Cadence (steps/min) and relative intensity in 61 to 85-year-olds: the CADENCE-Adults studyCayla R McAvoy, Taavy A Miller, Elroy J Aguiar, et al.
Eclinicalmedicine|October 17, 2024
Predicting mortality in febrile adults: comparative performance of the MEWS, qSOFA, and UVA scores using prospectively collected data among patients in four health-care sites in sub-Saharan Africa and South-Eastern AsiaSham Lal, Manophab Luangraj, Suzanne H Keddie, et al.
Eclinicalmedicine|March 2, 2026
Aetiology of sepsis in adults living with HIV in East Africa: a secondary analysis of an open-label, multicentre, randomised, controlled phase 3 trialEva Otoupalova, Lucas Ampaire, Megan Null, et al.
Journal of Clinical Microbiology|October 23, 2015
Development of a TaqMan Array Card for Acute-Febrile-Illness Outbreak Investigation and Surveillance of Emerging Pathogens, Including Ebola VirusJie Liu, Caroline Ochieng, Steve Wiersma, et al.
BMJ Global Health|October 31, 2017
Derivation and validation of a universal vital assessment (UVA) score: a tool for predicting mortality in adult hospitalised patients in sub-Saharan AfricaChristopher C Moore, Riley Hazard, Kacie J Saulters, et al.
The Lancet. Infectious Diseases|January 31, 2026
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trialScott K Heysell, Stellah G Mpagama, Edwin Nuwagira, et al.
Open Forum Infectious Diseases|July 3, 2023
Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program DirectorsVera P Luther, Alice E Barsoumian, Victoria J L Konold, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Antibiotics (Basel, Switzerland)|July 2, 2021
Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical IllnessPrakruti S Rao, Christopher C Moore, Amir A Mbonde, et al.
Critical Care Explorations|January 26, 2023
Overt and Occult Hypoxemia in Patients Hospitalized With COVID-19Shrirang M Gadrey, Piyus Mohanty, Sean P Haughey, et al.
The International Journal of Behavioral Nutrition and Physical Activity|November 30, 2023
Cadence (steps/min) and relative intensity in 61 to 85-year-olds: the CADENCE-Adults studyCayla R McAvoy, Taavy A Miller, Elroy J Aguiar, et al.
Eclinicalmedicine|October 17, 2024
Predicting mortality in febrile adults: comparative performance of the MEWS, qSOFA, and UVA scores using prospectively collected data among patients in four health-care sites in sub-Saharan Africa and South-Eastern AsiaSham Lal, Manophab Luangraj, Suzanne H Keddie, et al.
Eclinicalmedicine|March 2, 2026
Aetiology of sepsis in adults living with HIV in East Africa: a secondary analysis of an open-label, multicentre, randomised, controlled phase 3 trialEva Otoupalova, Lucas Ampaire, Megan Null, et al.
Journal of Clinical Microbiology|October 23, 2015
Development of a TaqMan Array Card for Acute-Febrile-Illness Outbreak Investigation and Surveillance of Emerging Pathogens, Including Ebola VirusJie Liu, Caroline Ochieng, Steve Wiersma, et al.
BMJ Global Health|October 31, 2017
Derivation and validation of a universal vital assessment (UVA) score: a tool for predicting mortality in adult hospitalised patients in sub-Saharan AfricaChristopher C Moore, Riley Hazard, Kacie J Saulters, et al.
The Lancet. Infectious Diseases|January 31, 2026
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trialScott K Heysell, Stellah G Mpagama, Edwin Nuwagira, et al.
Open Forum Infectious Diseases|July 3, 2023
Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program DirectorsVera P Luther, Alice E Barsoumian, Victoria J L Konold, et al.
Pageof 10